Product NDC: | 25021-204 |
Proprietary Name: | Vinorelbine |
Non Proprietary Name: | Vinorelbine |
Active Ingredient(s): | 10 mg/mL & nbsp; Vinorelbine |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-204 |
Labeler Name: | Sagent Pharmaceutical, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078011 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090914 |
Package NDC: | 25021-204-05 |
Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (25021-204-05) > 5 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 25021-204-05 |
Proprietary Name | Vinorelbine |
Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (25021-204-05) > 5 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 25021-204 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Vinorelbine |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20090914 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceutical, Inc. |
Substance Name | VINORELBINE TARTRATE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Vinca Alkaloid [EPC],Vinca Alkaloids [Chemical/Ingredient] |